Newsroom
News Coverage
Wall Street Daily: This Biotech Discovery Causes HIV to Self-Destruct.
(August 22, 2011)
READ MORE >>
Fast Company: A New Plan To Mutate HIV Out Of Existence.
(August 17, 2011)
READ MORE >>
Forbes: Embracing the Enemy-Most HIV drugs work by halting the virus' reproduction. Biotech firm Koronis has a different idea.
(July 20, 2011)
READ MORE >>
Dow Jones VentureWire Lifescience: Koronis Rebounds From Setback, Seeks New Funds For HIV Drug Trial. (June 16, 2011)
READ MORE >>
Forbes: With Koronis, Is A Cure For HIV On The Horizon? (June 13, 2011)
READ MORE >>
Koronis May Bring HIV Hope to Market
Daily Express, March 21, 2011
Koronis Looking for Financing for HIV Viral Decay Accelerator
BioWorld, March 16, 2011
The Telegraph: Koronis Pharmaceuticals exploring alternatives for financing the late-stage development of KP-1461 against HIV (March 14, 2011)
READ MORE >>
POZ Forum Post on KP-1461
POZ Forum, February 25, 2011
Podcast with Mark Fromhold, Ph.D., Koronis Pharmaceuticals. The significance of the KP-1461 clinical trial findings
Genetic Engineering News, February 22, 2011
Wedbush Securities: The Potential Disruptive Effect that Koronis Pharmaceuticals Could Have on the Existing HIV Market. (See page 4 of report). (January 26, 2011)
READ MORE >>
Benjamin Ryan, HIVPlusmag.com, July/August 2010
Genetic Engineering News: Need for Novel Approaches to Treating HIV Still Exists
Patricia F. Diamond, Ph.D., Genetic Engineering News, July 31, 2009
The New Virus Killer: Scientists try to turn HIV’s greatest strength—mutation—against itself
Gregory Mone, POPSCI.com, January 15, 2009
From Soup to Nuts
Drug Discovery & Development, April 01, 2008
Why Are Evolutionary Biologists Bringing Back Extinct Deadly Viruses?
The New Yorker, Annals of Science, Darwin’s Surprise, December 3, 2007
New Kind of Antiretroviral, KP-1461; Clinical Trial Recruiting
AIDS Treatment News, October 11, 2007
KP-1461 Novel Agent Enters Phase 2a Proof-of-Concept Study
Positively Aware, September/October 2007
Press Releases
Koronis Pharmaceuticals to Present at 2011 ChinaBio®Partnering Forum (May 4, 2011)
READ MORE >>
Clinical Trial Results Demonstrate Promise for First Non-suppressive HIV Drug (January 19, 2011)
READ MORE >>
Koronis Pharmaceuticals Announces Late-Breaker Oral Presentation on HIV Therapeutic Candidate KP-1461 at 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) (September 9, 2010)
READ MORE >>
Koronis Pharmaceuticals to Present at 2010 BIO International Convention (April 29, 2010)
READ MORE >>
Koronis Pharmaceuticals' Scientific Advisory Board Confirms KP-1461 Clinical Drug Activity, HIV Ablation (May 19, 2009)
READ MORE >>
Selected Articles
Dr. James Mullins Abstract - International HIV & Hepatitis Virus Drug Resistance Conference
Dr. James Mullins, June 9th, 2010
New HIV Drug Development a Problem
Jules Levin, December 4, 2008
2007 - A Look Back Over 20 Years
Mary Katz, MD, Being Alive Winter 2008 Newsletter
Stay Informed
To keep updated on Koronis' latest events and news releases, please go to our contact page and enter your name and email address to be added to our email news distribution list.